LABDDirexion Daily S&P Biotech Bear 3X Shares
LABD Fund Description
LABD provides daily 3 times inverse exposure to the S&P Biotechnology Select Industry Index.
LABD Factset Analytics Insight
LABD is a daily leveraged inverse (-3x) bet on an equal-weighted index of US biotech stocks. The vast majority of the fund's exposure is to biotechnology and medical research but also captures significant exposure to pharmaceuticals as well. As a leveraged product, the fund is not a buy-and-hold investment. It gets its leverage exposure through a through a portfolio of swaps that gets rebalanced at the end of each trading day. Because of that, the fund's return for periods longer than a day becomes path-dependent and is likely to be different from -3x the return of the index for the same period. This makes LABD suitable primarily for short-term traders. Over time, compounding effects can lead to profound differences in expected returns relative to the index.
LABD Factset Analytics Block Liquidity
This measurement shows how easy it is to trade a $1 million USD block of LABD. LABD is rated a N/A out of 5.